Emory University’s Neurogene NGNE Stock Holding History

Emory University’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,460	Closed	-$554K	–	49
2018 Q2	$554K	Buy	10,460 +1,502	+17%	+$391K	0.37%	44
2018 Q1	$2.52M	Buy	8,958 +438	+5%	+$121K	1.8%	19
2017 Q4	$2M	Buy	8,520 +2,357	+38%	+$552K	1.72%	16
2017 Q3	$1.75M	Buy	6,163 +872	+16%	+$250K	1.38%	23
2017 Q2	$1.49M	Sell	5,291 -312	-6%	-$89.3K	1.32%	42
2017 Q1	$1.87M	Sell	5,603 -1,582	-22%	-$556K	1.77%	20
2016 Q4	$2.37M	Buy	+7,185	New	+$1.93M	2.34%	3

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Emory University's NGNE Position: Q3 2018 in Review

Emory University sold out of Neurogene (NGNE) in Q3 2018, closing a stake of 10,460 shares — an estimated $554K sold.

Emory University first reported a position in NGNE in Q4 2016 and held it in 7 quarters. The position peaked at $2.52M in Q1 2018. 45 funds tracked by Wall St. Rank hold NGNE as of Q3 2018.

Emory University reported no remaining Neurogene position as of Q3 2018 after selling out during the quarter.
Emory University sold 10,460 Neurogene shares in Q3 2018, an estimated $554K.
Emory University first reported a position in Neurogene in Q4 2016 and held it in 7 quarters.
Emory University's Neurogene position peaked at $2.52M in Q1 2018.
45 funds tracked by Wall St. Rank held Neurogene as of Q3 2018.

Based on Emory University's 13F filing for Q3 2018, filed 14 Nov 2018.